Testing for hepatitis B virus in patients with chronic urticaria and angioedema

Insights

Hepatitis B virus (HBV) infection markers were found in 17.6% of chronic urticaria and angioedema (CUA) patients, a significantly higher rate than the general population. This suggests a potential link between HBV and CUA requiring further investigation.

Area of Science:

  • Hepatology
  • Immunology
  • Dermatology

Background:

  • Chronic urticaria and angioedema (CUA) is a complex condition with multifactorial etiologies.
  • Hepatitis B virus (HBV) infection is a significant global health concern.
  • Investigating potential infectious triggers for chronic inflammatory conditions is crucial.

Observation:

  • Serologic markers for HBV infection were assessed in 114 patients diagnosed with CUA.
  • Serum samples from 85 (75%) of these patients were analyzed for HBV markers.
  • The study aimed to determine the prevalence of HBV infection within this patient cohort.

Findings:

  • HBV infection markers were detected in 15 (17.6%) of the CUA patients.
  • Specifically, 13 patients (15.3%) showed evidence of past HBV infection (anti-HBs), and 2 patients (2.4%) had active infection (HBsAg).
  • The prevalence of HBV infection in CUA patients was notably higher than in the general population.

Implications:

  • The findings suggest a potential association between HBV infection and the development or exacerbation of CUA.
  • The two patients with HBsAg also received a diagnosis of chronic persistent hepatitis, highlighting a direct health consequence.
  • Further research is warranted to elucidate the causal relationship, if any, between HBV infection and CUA.